- Home
- SLAB vs XENE Comparison
SLAB vs XENE Comparison
Compare SLAB & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLAB
- XENE
- Stock Information
- Founded
- SLAB 1996
- XENE 1996
- Country
- SLAB United States
- XENE Canada
- Employees
- SLAB N/A
- XENE N/A
- Industry
- SLAB Semiconductors
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- SLAB Technology
- XENE Health Care
- Exchange
- SLAB Nasdaq
- XENE Nasdaq
- Market Cap
- SLAB 3.7B
- XENE 3.0B
- IPO Year
- SLAB 2000
- XENE 2014
- Fundamental
- Price
- SLAB $100.24
- XENE $39.83
- Analyst Decision
- SLAB Buy
- XENE Strong Buy
- Analyst Count
- SLAB 8
- XENE 10
- Target Price
- SLAB $118.14
- XENE $57.30
- AVG Volume (30 Days)
- SLAB 319.2K
- XENE 382.6K
- Earning Date
- SLAB 11-04-2024
- XENE 11-12-2024
- Dividend Yield
- SLAB N/A
- XENE N/A
- EPS Growth
- SLAB N/A
- XENE N/A
- EPS
- SLAB N/A
- XENE N/A
- Revenue
- SLAB $504,982,000.00
- XENE N/A
- Revenue This Year
- SLAB N/A
- XENE N/A
- Revenue Next Year
- SLAB $37.05
- XENE $1,600.08
- P/E Ratio
- SLAB N/A
- XENE N/A
- Revenue Growth
- SLAB N/A
- XENE N/A
- 52 Week Low
- SLAB $94.00
- XENE $28.20
- 52 Week High
- SLAB $154.91
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- SLAB 40.48
- XENE 39.07
- Support Level
- SLAB $103.89
- XENE $41.42
- Resistance Level
- SLAB $107.58
- XENE $44.61
- Average True Range (ATR)
- SLAB 4.93
- XENE 1.53
- MACD
- SLAB -0.68
- XENE -0.36
- Stochastic Oscillator
- SLAB 33.83
- XENE 2.99
About SLAB Silicon Laboratories Inc.
Silicon Laboratories Inc Inc. develops semiconductors, software, and system solutions for the Internet Internet of Things, Things (IoT), Internet infrastructure, industrial control, consumer, and automotive markets. The company operates through one segment, in a single segment of mixed-signal analog intensive products. The Company groups its products as Industrial & Commercial or Home & Life The Industrial & Commercial category contributes majority of the revenue for the company Geographically, the company operates in the United States, China, Taiwan, and the Rest rest of the world.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.